It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Coronary artery disease (CAD) is one of the most common pathological conditions and the major global cause of death. Myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) is a non-invasive method and plays an essential role in diagnosing CAD. However, there is currently a shortage of doctors who can diagnose using SPECT-MPI in developing countries, especially Vietnam. Research on deploying machine learning and deep learning in supporting CAD diagnosis has been noticed for a long time. However, these methods require a large dataset and are therefore time-consuming and labor-intensive. This study aims to develop a cost-effective and high-performance CAD classification model to support doctors in these countries. In this paper, we propose a transfer learning framework for a multi-stage training process with different learning rates. The process consists of two training stages: a warming up stage in which all layers of a pre-trained model (on ImageNet dataset) are frozen; and a fine-tuning stage in which a small amount of the top layers are unfrozen and then retrained with a lower learning rate. The dataset for this study consists of the polar maps from 218 patients. Various popular CNN-based pre-trained models have been investigated, and ResNet152V2-based model has obtained the highest performances with an accuracy of 95.5%, area under the receiver operating characteristic curve (AUC) score 0.932, sensitivity 94.4%, precision 96.4%, and F1-score 95.2%. These performances are competitive or even better than all state-of-the-art approaches in terms of classification accuracy and sensitivity. We also apply the class activation mapping technique to help explain the model’s predictions and increase the model’s reliability, proving capable of assisting the SPECT image readers in the CAD diagnosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer